Merck & Co., Inc. (MRK)
148.08
-2.83
(-1.88%)
USD |
NYSE |
Sep 23, 16:00
148.00
-0.08
(-0.05%)
Pre-Market: 07:45
Merck Cash from Operations (TTM) : 19.97B for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 19.97B |
| March 31, 2026 | 17.89B |
| December 31, 2025 | 16.47B |
| September 30, 2025 | 17.06B |
| June 30, 2025 | 18.53B |
| March 31, 2025 | 20.88B |
| December 31, 2024 | 21.47B |
| September 30, 2024 | 18.26B |
| June 30, 2024 | 16.69B |
| March 31, 2024 | 14.76B |
| December 31, 2023 | 13.01B |
| September 30, 2023 | 17.19B |
| June 30, 2023 | 15.08B |
| March 31, 2023 | 15.67B |
| December 31, 2022 | 19.10B |
| September 30, 2022 | 19.70B |
| June 30, 2022 | 18.89B |
| March 31, 2022 | 17.08B |
| December 31, 2021 | 14.11B |
| September 30, 2021 | 13.08B |
| June 30, 2021 | 10.46B |
| March 31, 2021 | 11.34B |
| December 31, 2020 | 10.25B |
| September 30, 2020 | 11.04B |
| June 30, 2020 | 13.09B |
| Date | Value |
|---|---|
| March 31, 2020 | 12.81B |
| December 31, 2019 | 13.44B |
| September 30, 2019 | 12.24B |
| June 30, 2019 | 10.80B |
| March 31, 2019 | 11.10B |
| December 31, 2018 | 10.92B |
| September 30, 2018 | 11.35B |
| June 30, 2018 | 7.385B |
| March 31, 2018 | 7.32B |
| December 31, 2017 | 6.451B |
| September 30, 2017 | 6.064B |
| June 30, 2017 | 10.21B |
| March 31, 2017 | 8.504B |
| December 31, 2016 | 10.38B |
| September 30, 2016 | 10.99B |
| June 30, 2016 | 11.32B |
| March 31, 2016 | 12.30B |
| December 31, 2015 | 12.42B |
| September 30, 2015 | 7.01B |
| June 30, 2015 | 8.053B |
| March 31, 2015 | 7.783B |
| December 31, 2014 | 7.86B |
| September 30, 2014 | 12.05B |
| June 30, 2014 | 11.65B |
| March 31, 2014 | 11.67B |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Johnson & Johnson | 27.61B |
| Eli Lilly & Co. | 28.08B |
| Pfizer Inc. | 13.40B |
| Bristol Myers Squibb Co. | 12.78B |
| Viatris, Inc. | 2.331B |